JPMORGAN CHASE & CO - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 112 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$447,000
-94.7%
10,342
-94.8%
0.00%
-100.0%
Q2 2015$8,426,000
+183.0%
199,392
+159.8%
0.00%
+100.0%
Q1 2015$2,977,000
+62.9%
76,746
+41.3%
0.00%
Q4 2014$1,827,000
-72.9%
54,297
-71.8%
0.00%
-100.0%
Q3 2014$6,744,000
-79.4%
192,602
-80.6%
0.00%
-75.0%
Q2 2014$32,670,000
-10.2%
994,216
+0.8%
0.01%
-20.0%
Q1 2014$36,373,000
-37.1%
986,758
-34.5%
0.01%
-37.5%
Q4 2013$57,849,000
-20.1%
1,507,262
-42.9%
0.02%
-23.8%
Q3 2013$72,377,000
+18.2%
2,641,481
-9.4%
0.02%
+5.0%
Q2 2013$61,251,0002,916,7230.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2013
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders